The National Heart, Lung, and Blood Institute is one of many Institutes in the National Institutes of Health that participate in the "Ruth L. Kirschstein National Research Service Award (NRSA) individual Senior Fellowship (Parent F33)". This program enables experienced scientists to change the direction of their research careers, broaden their scientific background, acquire new research capabilities, or enlarge their command of an allied research field.
When the fellowship begins, an applicant must have received the Ph.D., M.D., D.O., D.D.S., D.V.M., O.D., D.P.M., Sc.D., D.Eng., DNSc., or equivalent degree. The applicant also must have at least seven subsequent years of relevant postdoctoral research or professional training, and must have a sponsor affiliated with a public or private institution with appropriate facilities for the proposed training.
The applicant must arrange to work full-time with a particular sponsor affiliated with an institution that has the staff and facilities needed for the proposed training. Training can be conducted abroad if the site provides opportunities not available in the U.S. Applicants must be U.S. citizens, noncitizen nationals, or permanent residents of the U.S.
Individual Senior Fellowship NRSA: F33 Program Announcement (PA-14-151)
Who is eligible? All experienced scientists interested in changing the direction of their careers
The opportunities? Research training
Duration of support? Full-time for up to 2 years
Where? At research institutions
Applications due? April 8, August 8, and December 8
Allowable Costs: This F33 award provides a stipend, funds towards tuition and fees, and an Institutional Allowance which can be used to help defray fellowship expenses such as health insurance, research supplies, equipment, books, and travel to scientific meetings. See NOT-OD-14-046 for details.
Payback: One month of payback for each month of training, up to a maximum of 12 months. This requirement can be fulfilled by teaching or research (a minimum of 20 hours per week) on a continuous basis beginning within 2 years after support ends.
How to apply: Applications submitted in response to this Funding Opportunity Announcement (FOA) for Federal assistance must be submitted electronically through Grants.gov using the SF 424 Research and Related (R&R) forms and the SF 424 (R&R) Individual Fellowship Application Guide for use by NIH and AHRQ applicants.
Page Limitations: All page limitations described in the SF424 (R&R) Application Guide and the Table Of Page Limits must be followed.
Letters of Reference: Applicant fellows must carefully follow the SF424 (R&R) Individual Fellowship Application Guide, including the time period for when letters of reference will be accepted (letters are due by the application due date as described in the Notice). Note that neither the sponsor nor any co-sponsor of this application can be counted as a confidential reference. The sponsor/co-sponsor's recommendation is included as part of the application. Applications lacking the required reference letters will not be reviewed. This is a separate process from submitting an application electronically. Reference letters are submitted directly through the eRA Commons Submit Reference Letter link and not through Grants.gov.
Resources for F33 Candidates:
Please contact the following NHLBI staff member if you have questions about this award:
Charlotte A. Pratt, Ph.D., RD
Program Director, (responding for all NHLBI programmatic Divisions)
National Heart, Lung, and Blood Institute
Two Rockledge Center, Room 10118
6701 Rockledge Drive, MSC 7936
Bethesda, Maryland 20892-7936
Phone: (301) 435-0382
FAX: (301) 480-1864
Last Updated January 2017